Weill Medical College of Cornell University, Newyork, NY, USA.
Dig Dis Sci. 2013 Aug;58(8):2156-66. doi: 10.1007/s10620-013-2598-9. Epub 2013 Mar 2.
In this randomized clinical trial, we have compared the Shudh™ colon cleanse (SCC) with HalfLytely(®) colon prep (HCP) to evaluate the efficacy, bowel preparation time (BPT), adverse events, electrolyte abnormalities and patient acceptability.
Patients were randomized to receive either SCC (n = 65) or HCP (n = 68). All colonoscopies were performed by a single, blinded endoscopist. Colon prep was evaluated on a 5 point grading scale. Statistical non-inferiority was pre-defined as a difference of <15 % in the lower limit of the 95.5 % confidence interval for the treatment difference. Data that were collected include bowel prep score, BPT, adverse events, electrolyte abnormalities and patient acceptability.
Bowel preparation efficacy was rated as "successful" for 59/65 (90.7 %) in SCC versus 66/68 (97.1 %) in HCP. This gave a success difference of -6.4 % with a 1-sided 95 % lower confidence limit (LCI) for the difference = -13.3 % (non-inferiority p = 0.25). This difference fell within the predefined limit for non-inferiority. The average BPT for SCC was 1.9 h versus 10.9 in HCP (p < 0.001). No serious adverse events were reported in either group. None of the patients in either group had any clinically significant electrolyte imbalance. Patient ratings for palatability and willingness to repeat were significantly better for SCC (p < 0.05).
SCC was found to not be inferior to PEG with regards to the quality of bowel preparation. It is worth highlighting that a major advantage of SCC is shorter BPT.
在这项随机临床试验中,我们比较了 Shudh™ 结肠清洁剂(SCC)与 HalfLytely®(HCP)结肠准备,以评估疗效、肠道准备时间(BPT)、不良事件、电解质异常和患者可接受性。
患者随机分为 SCC 组(n = 65)或 HCP 组(n = 68)。所有结肠镜检查均由一名单独的、盲法内镜医生进行。肠道准备情况按 5 分制评分。预先定义的非劣效性差异为治疗差异的 95.5%置信区间下限的差异<15%。收集的数据包括肠道准备评分、BPT、不良事件、电解质异常和患者可接受性。
SCC 组肠道准备效果为“成功”的有 59/65(90.7%)例,HCP 组为 66/68(97.1%)例。成功率差异为-6.4%,单侧 95%置信区间下限(LCI)为差异=-13.3%(非劣效性 p = 0.25)。这一差异在预先设定的非劣效性范围内。SCC 组的平均 BPT 为 1.9 小时,HCP 组为 10.9 小时(p<0.001)。两组均无严重不良事件报告。两组患者均无任何临床显著的电解质失衡。SCC 组的口感和再次使用意愿评分显著优于 HCP 组(p<0.05)。
SCC 在肠道准备质量方面不劣于 PEG。值得强调的是,SCC 的一个主要优势是 BPT 更短。